3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Neuroblastoma
3
Myeloproliferative Disorders
3
Multiple Myeloma
3
Carcinoma, Ovarian Epithelial
3
Breast Neoplasms, Male
3
Wilms Tumor
2
Testicular Neoplasms
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Ovarian Neoplasms
2
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Neutrophilic, Chronic
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
Trastuzumab
8
Doxorubicin
8
Exercise
6
Cyclophosphamide
6
Echocardiography
5
Carvedilol
5
Docetaxel
4
Tablets
2
Silymarin
2
Radiotherapy
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Exercise Test
2
Epirubicin
2
Bisoprolol
2
Atorvastatin
2
Anthracyclines
2
sacubitril and valsartan sodium hydrate drug combination
1
nicotinamide-beta-riboside
1
mitoquinone
1
epicatechin gallate
1
empagliflozin
1
dapagliflozin
1
candesartan
1
Watchful Waiting
1
Therapeutics
1
Taxes
1
Tamoxifen
1
Social Determinants of Health
1
Secondary Prevention
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Amplified Fragment Length Polymorphism Analysis
×
Breast
×
Clear all
NCT00875238
2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
133 enrolled